Generalized Lipodystrophy
📧 Sign up to get email alerts when something new happens for Generalized Lipodystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]
Phase 3 trial assessing safety of Mibavademab in adults and children with Generalized Lipodystrophy switching from Metreleptin; study comple…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy [Phase 3]
Phase 3 trial evaluating efficacy and safety of Mibavademab for generalized lipodystrophy, currently recruiting in adult and pediatric patie…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]
Phase 3 study assessing the safety of switching from metreleptin to mibavademab in adults and children with Generalized lipodystrophy; the t…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy [Phase 4]
Phase 4 trial assessing the immunogenicity of metreleptin in patients with generalized lipodystrophy; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy [Phase 2]
Phase 2 study of REGN4461, a leptin receptor agonist antibody, in patients with Generalized Lipodystrophy has completed and results have bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trial of Leptin Replacement Therapy in Patients With Lipodystrophy [Phase 2, Phase 3]
Phase 2/3 trial evaluating leptin replacement therapy in lipodystrophy patients has completed with results posted.